DIN/PIN Detail - 02405334

280000   CENTRAL NERVOUS SYSTEM AGENTS
283200   ANTIMIGRAINE AGENTS
283228   SELECTIVE SEROTONIN AGONISTS

SANDOZ ALMOTRIPTAN 12.5 MG ORAL TABLET

(ALMOTRIPTAN MALATE)

Manufacturer:
SANDOZ CANADA INC.
ECDET Review Status/Past Decision(s):

 2014/01/02 - Restricted Benefit/Special Authorization


 2013/11/01 - Not a Benefit

CDR Status/Past Decision(s):
N/A

To return to the printable Drug Benefit List and related publications, click here.

Last Updated: null

NOTICE:
The DBL, DBS and related publications require knowledgeable interpretation and are intended primarily for professional health care practitioners, pharmacies, hospitals and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.

Electronic versions of all DBL and DBS related publications are unofficial versions and are provided for convenience and private use only. Official paper versions can be obtained from Alberta Blue Cross who publishes them on behalf of Alberta Health and Alberta Human Services.

Alberta Health reserves the right to make changes, without notice, to the List through the Interactive DBL(iDBL), and any such changes to the Interactive DBL(iDBL) are effective the date of the change (unless otherwise stated) and regardless of the date of publication in the paper version or updates.